|
 |
|
|
Why Devices are Failing in Oncology Drug Delivery ApplicationsAvailable on Demand
Date: January 14, 2016 – January 14, 2017
Duration: 30-minutes
Sponsored by:

About this webinar
One of pharma’s fastest-growing and highest-profile segments is facing a crisis. Some oncology drugs have demonstrated chemical incompatibility with traditional polymers used in delivery devices. Consequently, the ISMP and FDA have issued warnings for health professionals to stop using closed system drug-transfer devices made with polycarbonate or ABS plastics, which can leak, break, or dissolve following exposure to oncology drugs. Recent tests compare the chemical resistance of these polymers with Eastman Tritan™ copolyester.
You will learn:
- The growing therapeutic and economic importance of oncology drug therapy.
- The implications of recent ISMP and FDA warning statements for oncology drug delivery.
- How three engineering polymers withstand exposure to oncology drugs and carrier solvents under stress.
Speakers:
Cynthia Lewis
Market Insight and Strategy Manager, Medical
Eastman
Steven Givens, Ph.D.
Sr. Polymer Applications Scientist
Eastman Chemical Company
|
|
|
 |